Alessandro Gronchi retweeted
Featured: Well-Differentiated #Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes @alegronchi
ow.ly/BH9l50ZCGKA
@ZaidAbdelsattar
@SyedAAhmad5
@SocSurgOnc
Alessandro Gronchi retweeted
The #Sarculator app update is now live!
This comes together with our @TheLancetOncol paper introducing #BayeSarc, a Bayesian sequential learning approach to refine prognostication in extremity soft tissue #sarcoma.
Paper: sciencedirect.com/science/ar…
App: apps.apple.com/it/app/sarcul…
Alessandro Gronchi retweeted
The challenge of #surgonc is not only technical. It is about generating #evidence, making difficult decisions, organizing care, and keeping #innovation aligned with #patient benefit. @alegronchi opening this conversation @IstTumori at ‘The challenge of surgical oncology’.
Alessandro Gronchi retweeted
Proud to host the ISG–Patient Associations Meeting at #ISG2026.
From national networks to legislative progress, today’s program reflects our shared commitment to listen, collaborate, and act for people living with rare tumors.
Together, we move beyond paradigms. 💛
Alessandro Gronchi retweeted
The XXIX Annual Meeting of the Italian Sarcoma Group kicks off in Palermo 🇮🇹
250 attendees gathered to share science, collaboration, and new ideas in #sarcoma care. Looking forward to inspiring discussions over the next days! @ItaSarcomaGroup @SilviaStacchia @annamariafrezza
Diagnosis and treatment of primary soft tissue sarcomas: comprehensive review
➡️doi.org/10.1093/bjsopen/zraf…
This review outlines current diagnostic and treatment strategies for localized primary soft tissue sarcomas, with a separate focus on extremity/trunk and retroperitoneal disease. Key points include recent therapeutic advances, multidisciplinary management, and the centralization of care in high-volume centres to optimize outcomes.
👏👏👏Fahima Dossa , Eldad Elnekave , Aisha B Miah , Catherine Mitchell , Sarah Watson , @alegronchi , @FioreDoc
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery
Alessandro Gronchi retweeted
Building on terrific #SSO2026 and @TARPSWG meetings, check out our📄on current dx & tx strategies for soft tissue sarcoma @BjsOpen, including recent technical advances and multiD approaches
@ctosociety @SocSurgOnc @ESSOnews @_CSSO @FioreDoc @alegronchi
academic.oup.com/bjsopen/art…
Want to join us? Register for free membership at tarpswg.org
And save the date for next meeting in November 2026 in Seoul (in connection with @ctosociety meeting)
#Guidelines update for primary RPS planned for 2028
New #Guidelines specific for pelvic sarcoma underway
#ERAS projects to define official protocols for RPS
Much to come for #retroperitoneal #sarcoma: #STRASS3 for neoadjuvant tx in LPS will include ICI?
#RESAR registry now includes >3800 pts and new analyses are ongoing
#Delphi consensus to standardize terminology and approach to RPS expected in 2027
Alessandro Gronchi retweeted
Great to be in Phoenix for #SSO2026. Connecting with Sug Oncs worldwide amazing as always @alegronchi
Thanks for coming over. It was great to spend some time together!
Sarcoma family dinner 💛thank you @SilviaStacchia and @alegronchi for welcoming us into your home, workplace and international sarcoma family! @TARPSWG @ctosociety @UofTSurgOnc
1
14
985
1/ 🚨 When surgery is not enough: time to rethink patient selection in #retroperitoneal #sarcoma. Are we operating on tumor biology we don’t yet understand?
In primary RPS, ~20% of patients recur within 6 months after surgery — with survival comparable to unresected patients.
4/ The future is not just better surgery — it’s better selection:
🔬 biomarkers
🧠 AI prediction
💊 smarter neoadjuvant strategies
5/ If we want to improve outcomes, it’s time to change the paradigm.
#Sarcoma #RetroperitonealSarcoma #PrecisionOncology #AIinMedicine #CancerResearch, @ctosociety @ItaSarcomaGroup @eClinicalMed @ESSOnews @UofTSurgOnc @IstTumori @SocSurgOnc @TARPSWG
Alessandro Gronchi retweeted
Capire meglio i sarcomi, ascoltare esperti e testimonianze, scoprire il ruolo delle associazioni nella ricerca e nel supporto dei Pazienti: @ segui in streaming 👉 teams.microsoft.com/l/meetup… @FondFerrero @fumagallielena_ @alegronchi @SilviaStacchia @DAmbrosio_MD
Alessandro Gronchi retweeted
When p > 0.05 is not the end of the conversation. Fantastic Grand Round by @fdossa on how statistical misunderstandings can shape (and misshape) treatment decisions. A must-hear for clinicians. #sarcoma #clinicaltrials #statistics #oncology #surgery




























